Legato Capital Management LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1442641
San Francisco, CA
Position in SUPN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$534,027
-$195,215 QoQ
Shares Held
11,482
-18.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#178
of 331 holders
Holding Since
Dec 2022
15 quarters on record
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $3,175,895 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (16.8% of the industry book) .
All Filings in SUPN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,027 | 11,482 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $729,242 | 14,108 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $726,763 | 14,623 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $1,075,179 | 22,498 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $669,012 | 21,225 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $695,118 | 21,225 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $992,013 | 27,434 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $669,496 | 21,472 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $574,376 | 21,472 | Shares | Other | 2024-07-26 | |
| 2024-03-31 | $934,784 | 27,405 | Shares | Other | 2024-04-15 | |
| 2023-12-31 | $621,399 | 21,472 | Shares | Other | 2024-01-16 | |
| 2023-09-30 | $591,983 | 21,472 | Shares | Other | 2023-10-12 | |
| 2023-06-30 | $670,608 | 22,309 | Shares | Other | 2023-08-18 | |
| 2023-03-31 | $808,255 | 22,309 | Shares | Other | 2023-05-25 | |
| 2022-12-31 | $795,762 | 22,309 | Shares | Other | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||